United Therapeutics Corporation (UTHR) Insider Trading
- $999,400.80
- $735,699,860.15
- Sept. 3, 2024
- Martine A Rothblatt
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| May 17, 2013 | COO | 10,000 | $69.17 | Sell | $691,700.00 | |
| May 16, 2013 | EVP | 6,000 | $68.05 | Sell | $408,300.00 | |
| May 16, 2013 | CFO | 4,500 | $68.48 | Sell | $308,160.00 | |
| May 2, 2013 | Director | 3,000 | $66.75 | Sell | $200,250.00 | |
| May 2, 2013 | EVP | 6,000 | $67.15 | Sell | $402,900.00 | |
| April 11, 2013 | Director | 9,000 | $61.35 | Sell | $552,150.00 | |
| Jan. 17, 2013 | EVP | 5,749 | $52.20 | Sell | $300,097.80 | |
| Dec. 28, 2012 | CEO | 4,167 | $52.40 | Buy | $218,350.80 | |
| Dec. 26, 2012 | CEO | 6,000 | $52.40 | Buy | $314,400.00 | |
| Dec. 21, 2012 | CEO | 9,000 | $51.85 | Buy | $466,650.00 | |
| Nov. 26, 2012 | Director | 1,500 | $53.33 | Sell | $79,995.00 | |
| Oct. 4, 2012 | Director | 1,500 | $58.33 | Sell | $87,495.00 | |
| Oct. 4, 2012 | CFO | 1,550 | $58.00 | Sell | $89,900.00 | |
| Oct. 4, 2012 | EVP | 6,000 | $38.00 | Sell | $228,000.00 | |
| Sept. 6, 2012 | Director | 1,500 | $55.94 | Sell | $83,910.00 | |
| Sept. 5, 2012 | Director | 2,000 | $55.47 | Sell | $110,940.00 |
Insiders are both buying and selling United Therapeutics Corporation stock.
The insider traders at United Therapeutics Corporation are: Martine A Rothblatt, Paul A Mahon, Roger Jeffs, Martine A. Rothblatt, Martine Rothblatt, Christopher Causey, John Maxim Ferrari, Raymond Dwek, Christopher Patusky, Paul Mahon, David Zaccardelli, Richard Giltner, Nilda Mesa, Tommy G Thompson, Louis W Sullivan, Judy D Olian, Ray Kurzweil, Paul A. Mahon, R Paul Gray, James Edgemond, DWEK RAYMOND, MAHON PAUL A, Louis Sullivan, Tommy G. Thompson, Michael Benkowitz, and Judy D. Olian
The most active insider trader at United Therapeutics Corporation is Martine A Rothblatt with 386 trades.
Martine A Rothblatt has sold the most United Therapeutics Corporation stock with a total value of $372,318,923.20.
Martine A Rothblatt has bought the most United Therapeutics Corporation stock with a total value of $1,217,751.60.
The most recent insider trade for United Therapeutics Corporation was on Sept. 3, 2024.
The single biggest insider buy for United Therapeutics Corporation was from Martine A Rothblatt with a total value of $466,650.00 on Dec. 21, 2012.
The single biggest insider sell for United Therapeutics Corporation was from Michael Benkowitz with a total value of $8,084,500.00 on Aug. 7, 2024.